Peptone Announces Key Leadership Appointments to Progress Novel Protein Structural Insights for Intrinsically Disordered Protein-Driven Therapeutics

Proven leader, Kevin Tyler Sprott, PhD, appointed Chief Operating Officer Oncology and immunology drug development expert and industry leader, Andrew Allen, MD, PhD appointed as Executive Chairman LONDON and BELLINZONA, Switzerland, Jan. 9, 2025 /PRNewswire/ -- Peptone, a biotech company...